The haemophilia certification system in Canada.
作者信息
Matino Davide, Teitel Jerry, Page David, Keepanasseril Arun, Iorio Alfonso, Walker Irwin
机构信息
Health Information Research Unit, Department of Clinical Epidemiology and Biostatics, McMaster University, Hamilton, Canada.
St. Michaels Hospital, Toronto, Canada.
出版信息
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):e531-41. doi: 10.2450/2014.0032-14s.
Abstract
摘要
相似文献
1
The haemophilia certification system in Canada.加拿大的血友病认证系统。
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):e531-41. doi: 10.2450/2014.0032-14s.
2
Haemophilia Centre certification system across Europe: the Belgian experience.欧洲血友病中心认证系统：比利时的经验。
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s497-500. doi: 10.2450/2014.0061-14s.
3
Haemophilia Centre Certification Systems: optional or optimal choice for healthcare systems?血友病中心认证系统：医疗系统的可选还是最佳选择？
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s492-4. doi: 10.2450/2014.0076-14s.
4
The methodology for defining the European standards for the certification of Haemophilia Centres in Europe.欧洲血友病中心认证的欧洲标准定义方法。
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s519-24. doi: 10.2450/2014.0046-14s.
5
Current and evolving features in the clinical management of haemophilia.血友病临床管理中的当前及不断演变的特征
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s554-62. doi: 10.2450/2014.0043-14s.
6
The national haemophilia program standards, evaluation and oversight systems in the United States of America.美国的国家血友病项目标准、评估及监督系统。
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):e542-8. doi: 10.2450/2014.0019-14s.
7
Linking the world with training and research for improving haemophilia care.通过培训与研究连接世界，以改善血友病护理。
Haemophilia. 2008 Jul;14 Suppl 3:43-8. doi: 10.1111/j.1365-2516.2008.01712.x.
8
Quality of haemophilia care in The Netherlands: new standards for optimal care.荷兰血友病护理质量：最佳护理新标准
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s501-4. doi: 10.2450/2014.0041-14s.
9
Retrospective review of Acquired Haemophilia A from the largest Canadian Haemophilia treatment centre.对加拿大最大的血友病治疗中心的获得性血友病A进行回顾性研究。
Haemophilia. 2018 Sep;24(5):e383-e387. doi: 10.1111/hae.13598. Epub 2018 Aug 16.
10
Common themes and challenges in hemophilia care: a multinational perspective.血友病护理中的常见主题与挑战：跨国视角
Hematology. 2019 Dec;24(1):39-48. doi: 10.1080/10245332.2018.1505225. Epub 2018 Aug 3.
引用本文的文献
1
Inhibitor development according to concentrate in severe hemophilia: reporting on 1392 Previously Untreated Patients from Europe and Canada.重度血友病中依浓缩物进行抑制剂开发：来自欧洲和加拿大的1392例既往未治疗患者的报告。
Res Pract Thromb Haemost. 2023 Nov 20;7(8):102265. doi: 10.1016/j.rpth.2023.102265. eCollection 2023 Nov.
2
The existing scenario of haemophilia care in Canada and China - A review.加拿大和中国血友病护理的现状——综述
Hematol Transfus Cell Ther. 2020 Oct-Dec;42(4):356-364. doi: 10.1016/j.htct.2019.08.001. Epub 2019 Oct 27.
3
A survey of characteristics and current educational needs of hemophilia treatment centers within Asia Pacific.亚太地区血友病治疗中心的特征与当前教育需求调查。
Res Pract Thromb Haemost. 2018 May 24;2(3):508-517. doi: 10.1002/rth2.12108. eCollection 2018 Jul.
4
Haemophilia Centre Certification Systems: optional or optimal choice for healthcare systems?血友病中心认证系统：医疗系统的可选还是最佳选择？
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s492-4. doi: 10.2450/2014.0076-14s.
本文引用的文献
1
Inherited abnormalities of coagulation: hemophilia, von Willebrand disease, and beyond.遗传性凝血异常：血友病、血管性血友病及其他。
Pediatr Clin North Am. 2013 Dec;60(6):1419-41. doi: 10.1016/j.pcl.2013.09.002.
2
von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy.血管性血友病：发病机制理解、诊断和治疗的进展。
Blood. 2013 Nov 28;122(23):3735-40. doi: 10.1182/blood-2013-06-498303. Epub 2013 Sep 24.
3
The principal results of the International Immune Tolerance Study: a randomized dose comparison.国际免疫耐受研究的主要结果：一项随机剂量比较。
Blood. 2012 Feb 9;119(6):1335-44. doi: 10.1182/blood-2011-08-369132. Epub 2011 Nov 18.
4
Treatment of haemophilia: building on strength in the third millennium.血友病的治疗：在第三个千年中巩固优势。
Haemophilia. 2011 Nov;17 Suppl 3:1-24. doi: 10.1111/j.1365-2516.2011.02657.x.
5
Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.凝血因子浓缩物用于预防甲型或乙型血友病患者的出血及与出血相关的并发症。
Cochrane Database Syst Rev. 2011 Sep 7(9):CD003429. doi: 10.1002/14651858.CD003429.pub4.
6
Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors.重组凝血因子VIIa浓缩剂与血浆源性浓缩剂用于治疗血友病及有抑制剂患者的急性出血发作
Cochrane Database Syst Rev. 2010 Aug 4(8):CD004449. doi: 10.1002/14651858.CD004449.pub3.
7
Mortality and causes of death in Italian persons with haemophilia, 1990-2007.意大利血友病患者 1990-2007 年的死亡率和死因。
Haemophilia. 2010 May;16(3):437-46. doi: 10.1111/j.1365-2516.2009.02188.x. Epub 2010 Feb 9.
8
Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV.英国未感染艾滋病毒的甲型或乙型血友病患者的死亡率、预期寿命和死因
Blood. 2007 Aug 1;110(3):815-25. doi: 10.1182/blood-2006-10-050435. Epub 2007 Apr 19.
9
Blood safety monitoring among persons with bleeding disorders--United States, May 1998-June 2002.1998年5月至2002年6月美国出血性疾病患者的血液安全监测
MMWR Morb Mortal Wkly Rep. 2003 Jan 3;51(51-52):1152-4.
10
Causes of death in Canadians with haemophilia 1980-1995. Association of Hemophilia Clinic Directors of Canada.1980 - 1995年加拿大血友病患者的死因。加拿大血友病诊所主任协会。
Haemophilia. 1998 Sep;4(5):714-20. doi: 10.1046/j.1365-2516.1998.00179.x.
Zotero 插件